Reply - 02/10/14
Doi : 10.1016/j.jaci.2014.06.040
Yifang Gao, PhD a, Stephan Gadola, MD, PhD b, Bodo Grimbacher, MD c, Anthony P. Williams, MRCP, FRCPath, PhD a 
a Cancer Sciences Division, University of Southampton Faculty of Medicine, Southampton, United Kingdom
b Novartis, Basel, Switzerland
c Center for Chronic Immunodeficiency (CCI), University Medical Center Freiburg, Freiburg, Germany
Le texte complet de cet article est disponible en PDF.
| Y.G. and A.P.W. were supported by Cancer Research UK and the Experimental Cancer Medicine Centre, Southampton. B.G. was funded by the European Community's 6th and 7th Framework Programmes FP7/2007-2013 under grant agreements HEALTH-F2-2008-201549 (EURO-PADnet) and Health-F5-2008- 2223292 (Euro Gene Scan) and a Marie Curie Excellence Grant (MEXT-CT-2006-042316, MC-PIAID). |
|
| Disclosure of potential conflict of interest: Y. Gao has received research support from Cancer Research UK and is employed by the University of Southampton. B. Grimbacher has received research support from University College London and the Federal Ministry of Education and Research, is employed by the University Medical Center Freiburg, receives royalties from Springer, and has received travel support from CSL Baxter, Grifols, the European Union, BMBF, and the Jeffrey Modell Foundation. A. P. Williams has received research support from the National Institute of Health Research and Experimental Cancer Medicine Centre and is employed by the University of Southampton. S. Gadola declares no relevant conflicts of interest. |
© 2014
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 134 - N° 4
P. 990 - octobre 2014 Retour au numéro
Article précédent
- Invariant natural killer T cells in patients with common variable immunodeficiency
- Dominic Paquin-Proulx, Bianca A.N. Santos, Karina I. Carvalho, Myrthes Toledo-Barros, Ana Karolina B. Oliveira, Cristina M. Kokron, Jorge Kalil, Markus Moll, Esper G. Kallas, Johan K. Sandberg
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?